A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2023-08-09
Adverse events
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-08-25 (study day 2); relationship: N
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-09-18 (study day 26); relationship: Y
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-01-31 (study day 161); relationship: not assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-02-28 (study day 189); relationship: not assessed
Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2024-03-24 (study day 214); relationship: N
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2024-05-16 (study day 267); relationship: N
Data queries
No data queries.